N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine.

Norbert Handler; Thomas Erker; Walter Jäger; Philipp Saiko; Maria Ozsvar-Kozma; Astrid Bernhaus; Margit Jaschke; Geraldine Graser; Thomas Szekeres; Michael Grusch; Zsuzsanna Horvath; Georg Krupitza; Monika Fritzer-Szekeres; Andreas Lackner

N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine.

Norbert Handler, Thomas Erker, Walter Jäger, Philipp Saiko (Corresponding author), Maria Ozsvar-Kozma, Astrid Bernhaus, Margit Jaschke, Geraldine Graser, Thomas Szekeres (Corresponding author), Michael Grusch, Zsuzsanna Horvath, Georg Krupitza, Monika Fritzer-Szekeres, Andreas Lackner

Publications: Contribution to journal › Article › Peer Reviewed

Original language	English
Pages (from-to)	1261-1266
Number of pages	6
Journal	International Journal of Oncology
Volume	31
Issue number	5
Publication status	Published - 2007

Austrian Fields of Science 2012

301305 Medical chemistry
301304 Medical biology

Cite this

Handler, N., Erker, T., Jäger, W., Saiko, P., Ozsvar-Kozma, M., Bernhaus, A., Jaschke, M., Graser, G., Szekeres, T., Grusch, M., Horvath, Z., Krupitza, G., Fritzer-Szekeres, M., & Lackner, A. (2007). N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine. International Journal of Oncology, 31(5), 1261-1266.

Handler, Norbert ; Erker, Thomas ; Jäger, Walter et al. / N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine. In: International Journal of Oncology. 2007 ; Vol. 31, No. 5. pp. 1261-1266.

@article{a05bfe1882154b27adb7c0d629ae9146,

title = "N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine.",

author = "Norbert Handler and Thomas Erker and Walter J{\"a}ger and Philipp Saiko and Maria Ozsvar-Kozma and Astrid Bernhaus and Margit Jaschke and Geraldine Graser and Thomas Szekeres and Michael Grusch and Zsuzsanna Horvath and Georg Krupitza and Monika Fritzer-Szekeres and Andreas Lackner",

note = "***<REP_Import><OA_Full_2013>47225.28</OA_Full_2013></REP_Import>***04.01.2008: Datenanforderung 2057 (Import Sachbearbeiter) 09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)",

year = "2007",

language = "English",

volume = "31",

pages = "1261--1266",

journal = "International Journal of Oncology",

issn = "1019-6439",

number = "5",

}

Handler, N, Erker, T, Jäger, W, Saiko, P, Ozsvar-Kozma, M, Bernhaus, A, Jaschke, M, Graser, G, Szekeres, T, Grusch, M, Horvath, Z, Krupitza, G, Fritzer-Szekeres, M & Lackner, A 2007, 'N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine.', International Journal of Oncology, vol. 31, no. 5, pp. 1261-1266.

N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine. / Handler, Norbert; Erker, Thomas; Jäger, Walter et al.
In: International Journal of Oncology, Vol. 31, No. 5, 2007, p. 1261-1266.

Publications: Contribution to journal › Article › Peer Reviewed

TY - JOUR

T1 - N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: Synergistic antitumor activity with arabinofuranosylcytosine.

AU - Handler, Norbert

AU - Erker, Thomas

AU - Jäger, Walter

AU - Saiko, Philipp

AU - Ozsvar-Kozma, Maria

AU - Bernhaus, Astrid

AU - Jaschke, Margit

AU - Graser, Geraldine

AU - Szekeres, Thomas

AU - Grusch, Michael

AU - Horvath, Zsuzsanna

AU - Krupitza, Georg

AU - Fritzer-Szekeres, Monika

AU - Lackner, Andreas

N1 - ***<REP_Import><OA_Full_2013>47225.28</OA_Full_2013></REP_Import>***04.01.2008: Datenanforderung 2057 (Import Sachbearbeiter) 09.02.2010: Datenanforderung UNIVIS-DATEN-DAT.RA-2 (Import Sachbearbeiter)

PY - 2007

Y1 - 2007

M3 - Article

SN - 1019-6439

VL - 31

SP - 1261

EP - 1266

JO - International Journal of Oncology

JF - International Journal of Oncology

IS - 5

ER -